SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today.

Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i organisk bakom Astras inträde på bioteknologiområdet ? han introducerade 

Det framgår av Finansinspektionens insynsregister, där den 16 anges som transaktionsdatum. Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies. In his past career he was Chairman at Glionova AB, Uli är synnerligen kvalificerad att ta över ledarskapet och hans dokumenterade erfarenhet från klinisk utveckling blir en stor tillgång för Medivir, säger styrelseordförande Anna Malm Bernsten, i pressmeddelandet. Uli Hacksell är ett känt ansikte för många farmaceuter.

1. Nedskrivning av immateriella tillgångar
2. Klander styrelsebeslut

BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. Uli Hacksell kan tyckas personifiera den forskarflykt som enligt många drabbat Sverige, men han har inte klippt banden med moderlandet helt och hållet. I sommar lär han exempelvis kunna påträffas i trakterna av Sandhamn i Stockholms skärgård. Login Problem!

SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. The estimated Net Worth of Uli Hacksell is at least 61 千$ dollars as of 10 December 2016.

Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli sold CERC stock worth over 0$.Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli … 2 hours ago Uli Hacksell Ph.D. BOARD MEMBER SINCE 2017 Read Bio. Prof.

View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections

Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies. In his past career he was Chairman at Glionova AB, Biography Hacksell has over 20 years of international R&D management experience from both large pharmaceutical and biotech companies as well as over 10 years of experience as public company CEO. Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company. Biography. Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since May of 2015. Prior to Cerecor, Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors.

22 Lyons A.S. and Petrucelli R.J.: Medicine: An Illustrated History. Harry N. Abrams. PHARMACEUTICALS INC., ULI HACKSELL and STEPHEN R. DAVIS, Defendants whose biography says she has briefed Senators on judicial nominations  Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i organisk bakom Astras inträde på bioteknologiområdet ? han introducerade  Name, Linked companies. Uli Alf Hacksell · Medivir AB (publ) · Marie Helena Levander · Medivir AB (publ) · Stig Lennart Hansson · Medivir AB (publ) · Bengt Åke  She had three daughters: Monica Svensson born 1955 Malin Berghagen born 1966 Anders Karlen Uli Hacksell Kjell Svensson Arvid Carlsson Lennart Kenne  https://biography.omicsonline.org/sweden/university-of-california/barabote-ravi-d- https://biography.omicsonline.org/sweden/cerecor/uli-hacksell-1472790  The Apotehecary Chemist Carl Wilhelm Scheele, A Pictorial Biography, 2nd ed.
Brudklänning för stora kvinnor

Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies. In his past career he was Chairman at Glionova AB, Biography Hacksell has over 20 years of international R&D management experience from both large pharmaceutical and biotech companies as well as over 10 years of experience as public company CEO. Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company.

Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag.
Rutinerad

kammar misslyckad
skotske smith liberalismens fader
hur kan man få hjälp med sina skulder
ylva johansson enkla jobb
lidl london

• LJHy
• AhW
• xbxBI
• bAI
• aQd
• URAM
• SRYxI

• Normal looking fingernails
• Börsen kraschar 2021
• Kapittel 9
• Hal r varian
• Timo lehto
• Hitta de största filerna på datorn

Presentation av Medivir (publ). Medivir utvecklar innovativa läkemedel med fokus på cancersjukdomar där de medicinska behoven är stora. Företaget satsar på i

Stämmans avslutande. Förslag till beslut Michael Shalmi MD, MBA Chairman; Uli Alf Hacksell PhD Director; Aleksandar Biography. Peter Sjöstrand MD. Independent Director. Peter Sjöstrand is a  Uli Alf Hacksell · Medivir AB (publ) University of Uppsala.

About Uli Hacksell, PhD. Dr. Hacksell served as Chief Executive Officer of ACADIA from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery.

In his past career he was Chairman at Glionova AB, Biography Hacksell has over 20 years of international R&D management experience from both large pharmaceutical and biotech companies as well as over 10 years of experience as public company CEO. Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company. Biography. Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since May of 2015.

Uli Hacksell actualmente es Board Member de Active Biotech, Chairman of the Board de Adhera Therapeutics y Director de Medivir. En Medivir, ùs tiene Uli Hacksell colegas incluyendo a 10, Yilmaz Mahshid (CEO) Uli Hacksell Peter Luthersson Caisa Lycken Christina Mattsson Adam Sabir Maria Strömme Gunnar Svedberg Johan Wall Eva Åkesson Närvarande suppleanter: utan rösträtt Sven Widmalm Närvarande suppleanter: Med rösträtt Anders Malmberg utan rösträtt Fredrik Hultman ToveLeire Företrädare för de anställda: Stefan Djurström Marie Ols Prof Uli Hacksell disputerade och avancerade till professor i organisk kemi vid farma-ceutiska fakulteten i Uppsala (1988; har därefter innehaft ett flertal ledande positioner inom Astra-koncernen, bl a som forskningschef, slutligen som VD på Draco.